The University of Vermont and State Agricultural College, more commonly known as the University of Vermont or UVM, is a public research university and, after 1862, the U.S. state of Vermont's land-grant university. The University of Vermont is labeled one of the original "Public Ivies," a publicly funded university considered as providing a quality of education comparable to those of the Ivy League.Founded in 1791, UVM is among the oldest universities in the United States and the fifth college established in New England after Harvard, Yale, Dartmouth and Brown.The university's 451-acre campus is located in Burlington. Features of the UVM campus include the historic University Green, the Dudley H. Davis Center—the first student center in the nation to receive U.S. Green Building Council LEED Gold certification—the Fleming Museum of Art, and the Gutterson/Patrick athletic complex, home to UVM's Division I athletic teams. The largest hospital complex in Vermont, The University of Vermont Medical Center, has its primary facility adjacent to the UVM campus and is affiliated with the UVM College of Medicine. Wikipedia.
Lewinter M.M.,University of Vermont
New England Journal of Medicine | Year: 2014
A previously healthy 25-year-old man presents with pleuritic pain in the left side of the chest of 3 hours' duration, radiating to the left trapezius ridge and relieved by sitting forward. On physical examination, he appears anxious. His pulse is 104 beats per minute and regular, his blood pressure is 125/80 mm Hg without a paradoxical pulse, and his temperature is 37.8°C. A three-component friction rub is auscultated along the left sternal border. An electrocardiogram (ECG) reveals ST-segment elevations in multiple leads, which are consistent with acute pericarditis. How should this case be managed?. Copyright © 2014 Massachusetts Medical Society. Source
Rincon M.,University of Vermont
Trends in Immunology | Year: 2012
The incidence and diversity of chronic inflammatory diseases is increasing worldwide. However, the complexity of clinical symptoms has made it difficult to develop therapies that provide a substantial improvement for extended periods of time in a wide range of patient groups. Thus, there is a need for new therapies that target inflammatory responses without compromising immune defense. Interleukin (IL)-6, one of the first identified cytokines, has recently been recognized as a potential target in inflammatory disease. Here, I discuss how this cytokine has evolved from being a marker of inflammation to a successful target to control inflammation. I will summarize the results from the recent clinical studies using IL-6 receptor blockade, and describe potential mechanisms by which IL-6 can contribute to the progression of inflammatory diseases. © 2012 Elsevier Ltd. Source
University of Vermont | Date: 2014-03-13
The present invention relates to methods for measuring molecular interactions in a viscoelastic material, as well as related products and kits. The methods involve, for instance, taking multiple pressure measurements in the viscoelastic material and calculating the complex modulus from the pressure measurements to produce the measurement of viscoelastic properties in the viscoelastic material. Also included in the invention are methods and systems for detecting molecular interactions in vivo.
University of Vermont | Date: 2014-11-07
A system for processing signals to enhance patient audibility of a plurality of signals in an MRI environment is provided. The system includes an acoustic measuring device for measuring sound power levels generated by the M RI and a principal frequency component identifier for identifying principal frequencies measured by the acoustic measuring device. The system also includes an audio equalizer for controlling the amplitude and frequency of each of the plurality of signals in accordance with the principal frequencies. Further provided by the system is an attenuator for attenuating an overall sound level of the signals being processed and a dynamic range compression processor.
University of Vermont | Date: 2014-04-20
The Portable Ultrafine Particle Sizer (PUPS) invention is provided. The PUPS is an instrument which can measure particle number concentration for particle sizes under 200 nanometers in-situ. The PUPS is a compact design for quick mounting on vehicles. Size discrimination is accomplished using a compact reverse Differential Mobility Analyzer (rDMA). Particle charging is accomplished using corona ionization. Concentration measurements are completed using a unique flexible printed circuit board electrode which can be removed for cleaning, disposal or chemical analysis of collected particles at the end of its in situ measurement life.